ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce

7680664170061 CH-66417 C10AA07 07.12.0.

Reimbursement limitations:

ROSUVASTMeph

Chez les adultes de 18 à 75 ans, le traitement par statines est remboursé en …

ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce
ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce
ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce
1 / 3
google

Details

Product number
6641702
CPT
-
Packaging group
100
Unit
Tablette(n)
Composition
Tablette: rosuvastatinum 10 mg ut rosuvastatinum calcicum, cellulosum microcristallinum, lactosum monohydricum 97.97 mg, crospovidonum, hydroxypropylcellulosum, natrii hydrogenocarbonas corresp. natrium 0.14 mg, magnesii stearas, Überzug: lactosum monohydricum 2.2 mg, hypromellosum, triacetinum, E 171, E 172 (rubrum), pro compresso obducto.

Articles (1)

Rosuvastatin-Mepha 10 mg, Filmtablette
Filmtablette
100
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
03/10/2025
Patient information leaflet
Français
03/10/2025
Patient information leaflet
Italien
03/10/2025
Professional SmPC
Allemand
03/10/2025
Professional SmPC
Français
03/10/2025
Professional SmPC
Italien
03/10/2025

Detailed composition

Substance Quantity Type Category
TAB
10.0 MG Substance Wirkstoff (Principe actif)
TAB
- Substance WIZUS
TAB
- Substance HNIDK
TAB
97.97 MG Substance HBESI
TAB
- Substance HNIDK
TAB
- Substance HNIDK
TAB
- Substance HNIDK
TAB
0.14 MG Substance HBESI
TAB
- Substance HNIDK
TAB
1.156 MG Substance HBESI
TAB
- Substance HNIDK
TAB
- Substance FNIDK
TAB
- Substance HNIDK
TAB
- Substance FTODK

Reimbursement information

Public price
CHF 45.80
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

Mepha Pharma AG

4051 Basel

Authorization information

Swissmedic authorization number
66417
Drug name
Rosuvastatin-Mepha, Filmtablette
Galenic form
FILM
ATC Code
C10AA07
Authorization status
Z
Dispensation category
B
First authorization
18/04/2017
Authorization expiration date
31/12/9999
IT number
07.12.0.
Domain
Human medicine
Field of application
Reduktion der Serumcholesterinkonzentration. Vorbeugung kardiovaskulärer Ereignisse bei Erwachsenen mit normalem LDL-Cholesterin Spiegel und erhöhtem Risiko von atherosklerotischen kardiovaskulären Erkrankungen

Packaging details

Description (FR)
ROSUVASTATIN Mepha cpr pell 10 mg bte 100 pce
Description (DE)
ROSUVASTATIN Mepha Filmtabl 10 mg Ds 100 Stk
Market launch
18/04/2017
Narcotic (BTM)
No

Original drug

Crestor, Filmtabletten
CHF 29.50
View original

Other packaging sizes

ROSUVASTATIN Mepha cpr pell 5 mg 30 pce
30 TABL
View
ROSUVASTATIN Mepha cpr pell 5 mg 100 pce
100 TABL
View
ROSUVASTATIN Mepha cpr pell 5 mg bte 100 pce
100 TABL
View
ROSUVASTATIN Mepha cpr pell 10 mg 30 pce
30 TABL
View
ROSUVASTATIN Mepha cpr pell 10 mg 100 pce
100 TABL
View
ROSUVASTATIN Mepha cpr pell 20 mg 30 pce
30 TABL
View
ROSUVASTATIN Mepha cpr pell 20 mg 100 pce
100 TABL
View
ROSUVASTATIN Mepha cpr pell 20 mg bte 100 pce
100 TABL
View